Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.